bf/NASDAQ:CSBR_icon.jpeg

COM:CHAMPIONSONCOLOGY

Champions Oncology

  • Stock

Last Close

3.79

31/10 16:04

Market Cap

69.87M

Beta: -

Volume Today

19.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '14
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
Apr '24
average inventory
average payables
1.09M
-
1.20M
9.61%
1.66M
38.20%
1.87M
13.23%
2.00M
6.88%
2.48M
23.84%
2.97M
19.88%
2.52M
15.35%
2.38M
5.40%
4.10M
72.24%
average receivables
911K
-
1.19M
30.90%
1.19M
0.55%
1.79M
51.18%
3.10M
72.64%
4.15M
33.97%
4.57M
10.28%
5.88M
28.52%
8.25M
40.35%
8.76M
6.21%
book value per share
0.57
-
0.93
62.53%
0.03
97.05%
0.04
33.22%
-0.00
106.24%
0.20
8,786.01%
0.45
127.53%
0.57
25.90%
0.69
21.92%
0.34
50.33%
capex per share
-0.04
-
-0.01
67.21%
-0.04
170.50%
-0.07
88.56%
-0.11
60.14%
-0.07
34.16%
-0.19
154.88%
-0.25
33.22%
-0.18
27.66%
-0.21
17.41%
-0.06
70.90%
capex to depreciation
-1.10
-
-0.56
49.38%
-2.06
271.19%
-4.56
120.90%
-3.41
25.13%
-1.38
59.69%
-2.69
95.53%
-2.77
2.98%
-1.47
47.12%
-1.28
12.73%
-0.45
64.98%
capex to operating cash flow
0.07
-
0.01
81.87%
0.05
303.87%
0.27
440.44%
1.00
271.66%
-0.45
144.68%
-0.76
70.62%
1.95
355.41%
-0.37
118.80%
-0.73
97.90%
0.14
118.76%
capex to revenue
-0.02
-
-0.01
33.73%
-0.03
114.47%
-0.05
72.61%
-0.06
22.16%
-0.03
49.25%
-0.07
124.29%
-0.08
15.68%
-0.05
39.28%
-0.05
9.82%
cash per share
1.05
-
1.08
2.41%
0.30
72.38%
0.30
1.03%
0.08
74.07%
0.29
266.92%
0.70
146.76%
0.36
49.35%
0.68
91.32%
0.75
9.48%
days of inventory on hand
days payables outstanding
57.17
-
67.62
18.27%
79.67
17.83%
69.67
12.56%
74.50
6.94%
71.82
3.59%
67.89
5.48%
32.19
52.58%
44.30
37.60%
65.93
48.83%
days sales outstanding
41.87
-
43.65
4.25%
42.83
1.90%
53.86
25.76%
70.63
31.15%
59.02
16.44%
54.20
8.17%
62.13
14.64%
70.70
13.80%
54.28
23.23%
debt to assets
0.00
-
0.00
60.44%
0.18
12,786.27%
0.35
90.12%
0.27
23.11%
0.25
6.33%
debt to equity
-1.16
-
0.01
100.62%
0.71
9,889.57%
1.29
80.98%
1.04
19.49%
1.85
78.23%
dividend yield
earnings yield
-0.12
-
-0.21
70.65%
-0.31
51.10%
-0.24
23.53%
-0.03
86.76%
0.00
103.94%
-0.02
1,837.67%
0.00
110.97%
0.01
128.22%
-0.08
1,599.31%
-0.11
36.60%
enterprise value
55.38M
-
54.34M
1.87%
30.93M
43.09%
25.59M
17.27%
46.89M
83.24%
99.75M
112.74%
86.89M
12.89%
145.90M
67.91%
101.81M
30.21%
64.29M
36.85%
enterprise value over ebitda
-9.16
-
-4.17
54.44%
-3.04
27.04%
-3.85
26.57%
-47.17
1,124.23%
113.87
341.40%
-282.10
347.75%
95.86
133.98%
45.57
52.46%
-46.06
201.05%
ev to operating cash flow
-16.13
-
-5.64
65.02%
-4.79
15.05%
-9.01
87.95%
-38.24
324.47%
53.57
240.07%
29.91
44.17%
-86.79
390.18%
15.67
118.06%
16.26
3.74%
ev to sales
4.79
-
6.13
27.88%
2.77
54.89%
1.66
39.97%
2.32
39.51%
3.69
59.09%
2.70
26.60%
3.55
31.43%
2.07
41.68%
1.19
42.43%
free cash flow per share
-0.65
-
-1.12
71.41%
-0.78
30.54%
-0.33
57.81%
-0.22
32.05%
0.09
140.63%
0.06
36.20%
-0.38
752.95%
0.31
182.52%
0.08
74.34%
-0.51
743.57%
free cash flow yield
-0.06
-
-0.15
155.71%
-0.20
32.07%
-0.12
38.23%
-0.05
58.78%
0.01
119.40%
0.01
24.96%
-0.04
569.79%
0.04
215.30%
0.02
59.45%
-0.11
744.90%
graham net net
0.22
-
0.71
227.16%
-0.23
131.95%
-0.24
5.03%
-0.39
64.76%
-0.22
43.55%
-0.30
34.18%
-0.78
162.62%
-0.77
1.38%
-1.00
30.22%
graham number
4.11
-
5.61
36.35%
0.86
84.68%
0.72
16.58%
0.08
88.33%
0.22
167.73%
1.30
479.78%
0.57
56.19%
0.80
41.12%
1.74
117.09%
income quality
0.46
-
0.73
58.10%
0.62
15.72%
0.41
33.21%
0.81
97.46%
14.55
1,685.73%
-1.47
110.11%
-5.03
242.17%
11.86
335.57%
-0.74
106.25%
0.84
213.78%
intangibles to total assets
0.08
-
0.06
26.40%
0.12
108.53%
0.08
27.89%
0.08
0.83%
0.06
28.29%
0.02
72.82%
0.01
24.79%
0.01
22.01%
0.01
3.11%
0
100%
interest coverage
6.92
-
25.29
-
interest debt per share
0.00
-
0.00
84.02%
0.32
6,512.01%
0.73
127.87%
0.72
1.59%
0.64
11.69%
inventory turnover
invested capital
-1.16
-
0.01
100.62%
0.71
9,889.57%
1.29
80.98%
1.04
19.49%
1.85
78.23%
market cap
61.27M
-
63.70M
3.97%
33.51M
47.39%
28.88M
13.82%
47.70M
65.15%
102.97M
115.86%
91.43M
11.20%
140.98M
54.19%
101.35M
28.11%
65.81M
35.07%
65.71M
0.16%
net current asset value
1.93M
-
6.78M
251.22%
-1.20M
117.70%
-1.74M
45.29%
-3.04M
74.68%
-1.10M
63.69%
-1.94M
75.20%
-7.53M
289.10%
-6.62M
12.15%
-10.22M
54.40%
net debt to ebitda
0.97
-
0.72
26.25%
0.25
64.59%
0.50
95.01%
0.82
65.05%
-3.68
549.00%
14.75
501.24%
3.23
78.12%
0.21
93.64%
1.09
429.59%
net income per share
-1.32
-
-1.51
14.39%
-1.20
20.53%
-0.63
47.76%
-0.14
78.18%
0.01
108.25%
-0.17
1,577.40%
0.03
115.24%
0.04
63.35%
-0.39
1,048.78%
-0.54
36.32%
operating cash flow per share
-0.61
-
-1.11
80.86%
-0.74
33.02%
-0.26
65.11%
-0.11
56.91%
0.16
247.36%
0.25
49.39%
-0.13
152.16%
0.49
484.79%
0.29
40.67%
-0.45
255.10%
payables turnover
6.38
-
5.40
15.45%
4.58
15.13%
5.24
14.36%
4.90
6.49%
5.08
3.73%
5.38
5.79%
11.34
110.88%
8.24
27.32%
5.54
32.81%
receivables turnover
8.72
-
8.36
4.08%
8.52
1.93%
6.78
20.48%
5.17
23.75%
6.18
19.67%
6.73
8.90%
5.87
12.77%
5.16
12.13%
6.72
30.26%
research and ddevelopement to revenue
0.20
-
0.55
178.76%
0.38
31.39%
0.28
25.73%
0.22
21.95%
0.18
18.47%
0.18
2.79%
0.18
3.77%
0.19
8.86%
0.21
12.28%
return on tangible assets
-0.90
-
-1.15
27.84%
-2.05
77.08%
-0.94
54.15%
-0.20
78.34%
0.01
105.95%
-0.10
900.81%
0.01
112.67%
0.02
27.61%
-0.16
1,104.11%
revenue per share
2.06
-
1.02
50.53%
1.28
26.12%
1.40
9.24%
1.84
31.09%
2.39
29.75%
2.71
13.64%
3.12
15.16%
3.72
19.13%
3.98
6.91%
roe
-2.32
-
-1.63
29.62%
-43.89
2,591.90%
-17.21
60.79%
60.20
449.80%
0.06
99.90%
-0.37
749.34%
0.04
112.11%
0.06
33.98%
-1.15
2,010.12%
roic
-1.96
-
-1.66
15.49%
-43.73
2,536.44%
-17.07
60.97%
-353.29
1,969.69%
0.07
100.02%
-0.12
284.63%
0.01
108.52%
0.02
96.40%
-0.21
1,113.89%
sales general and administrative to revenue
0.53
-
0.60
13.58%
0.46
23.22%
0.32
30.39%
0.20
37.55%
0.17
14.07%
0.21
19.13%
0.16
22.93%
0.19
17.00%
0.19
2.39%
shareholders equity per share
0.57
-
0.93
62.53%
0.03
97.05%
0.04
33.22%
-0.00
106.24%
0.20
8,786.01%
0.45
127.53%
0.57
25.90%
0.69
21.92%
0.34
50.33%
stock based compensation to revenue
0.24
-
0.36
46.80%
0.23
34.85%
0.17
25.68%
0.05
71.28%
0.02
52.63%
0.02
20.51%
0.01
21.99%
0.02
27.45%
0.02
13.64%
tangible asset value
2.53M
-
7.39M
192.33%
-431K
105.83%
-269K
37.59%
-694K
157.99%
1.57M
326.08%
4.98M
217.59%
7.09M
42.34%
8.76M
23.52%
4.30M
50.91%
tangible book value per share
0.45
-
0.85
88.47%
-0.05
105.83%
-0.02
50.53%
-0.06
157.50%
0.14
319.36%
0.42
204.10%
0.54
28.31%
0.66
22.97%
0.32
52.16%
working capital
3.94M
-
6.97M
76.83%
-966K
113.87%
-1.58M
63.35%
-2.42M
53.49%
-103K
95.75%
1.41M
1,470.87%
1.43M
1.35%
2.19M
52.69%
-2.28M
204.16%

All numbers in (except ratios and percentages)